Celex Oncology Innovations Ltd.

Calculating rank

USPTO Granted Patents = 4

EPO Patents = 3

Forward Citations = 0

Loading Chart...

2 inventors (with patents filed for the assignee):

Mustafa Bilgin Ali Djamgoz (4 out of 6 patents)

Carsten Faltum (2 out of 2 patents)

Carsten Faltum (1 out of 2 patents)

4. Leif Helth Jensen (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12624101 - MONOCLONAL ANTIBODIES AGAINST NEONATAL NAV1.5 (2026-05-12),

2. 12605390 - Treatment of cancer and inhibition of metastasis (2026-04-21),

3. 12534444 - Treatment of cancer/inhibition of metastasis (2026-01-27),

4. 12508260 - COMBINATION TREATMENTS (2025-12-30),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#13 in Liverpool

#3,873 in United Kingdom

Liverpool, United Kingdom

Celex Oncology Innovations Ltd.

Forward Citations = 0

2 inventors:

Mustafa Bilgin Ali Djamgoz (4 out of 6 patents)

Carsten Faltum (2 out of 2 patents)

Carsten Faltum (1 out of 2 patents)

4. Leif Helth Jensen (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celex Oncology Innovations Ltd.. Retrieved from https://idiyas.com/company/celex-oncology-innovations

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]